Arch Biopartners (TSXV:ARCH) Cash Flow for Dividends : C$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Cash Flow for Dividends?

Arch Biopartners's cash flow for dividends for the three months ended in Dec. 2024 was C$0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Arch Biopartners Cash Flow for Dividends Historical Data

The historical data trend for Arch Biopartners's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Cash Flow for Dividends Chart

Arch Biopartners Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Cash Flow for Dividends

Get a 7-Day Free Trial

Arch Biopartners Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Arch Biopartners Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Arch Biopartners Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

ACHFF:USA

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.